A reappraisal of the strength-duration test to assess neuromuscular impairment of critically ill patients.

Clinical electrophysiology Critical illness myopathy and/or polyneuropathy Electromyography Electroneurography Intensive care unit acquired weakness Neuromuscular electrical stimulation Peroneal nerve test Strength-duration test

Journal

Journal of electromyography and kinesiology : official journal of the International Society of Electrophysiological Kinesiology
ISSN: 1873-5711
Titre abrégé: J Electromyogr Kinesiol
Pays: England
ID NLM: 9109125

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 09 09 2020
revised: 26 04 2021
accepted: 28 04 2021
pubmed: 18 5 2021
medline: 20 8 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Neuromuscular impairment (NMI) affects almost half of critically ill patients. The purpose was to investigate the role of neuromuscular electrical stimulation (NMES) to gain more insight into the nature of the NMI associated with ICU admission. To this aim, we analyzed the strength-duration (S-D) curves of the rectus femoris muscles of ICU patients compared to healthy volunteers. S-D curves were recorded from 44 healthy volunteers and 29 ICU patients. Three electrophysiological parameters were used to classify the neuromuscular function, from grade 0 (normal function), to grade 3 (no evocable muscle contraction). ICU patients underwent electroneurographic peroneal nerve testing (PENT) to analyze NMI by electroneurography (ENG). Three patients were classified as Grade 0; nine as mild NMI (Grade 1), 13 as Grade 2, and four showed unexcitable muscles (Grade 3). Mean CMAP amplitudes were 6.1, 3.4, 2.9 and 0.81 mV from Grade 0 to Grade 3, respectively. CMAP was inversely correlated to NMI grade (-1.7 mV, R The normative parameters of the S-D curves obtained by NMES in healthy volunteers allowed identification of NMI in ICU patients. NMES was an affordable tool to evaluate NMI in ICU patients, providing additional information to that obtained by ENG.

Identifiants

pubmed: 34000696
pii: S1050-6411(21)00042-0
doi: 10.1016/j.jelekin.2021.102555
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102555

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Nazzareno Fagoni (N)

Department of Anesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, University of Geneva, Switzerland; AAT Brescia, Azienda Regionale Emergenza Urgenza (AREU), ASST Spedali Civili di Brescia, Italy. Electronic address: nazzarenofagoni@gmail.com.

Guido Ferretti (G)

Department of Anesthesiology, Clinical Pharmacology, Intensive Care and Emergency Medicine, University of Geneva, Switzerland; Department of Molecular and Translational Medicine, University of Brescia, Italy; Laboratory of Integrative and Clinical Physiology (FCI lab), University of Brescia, Italy.

Simone Piva (S)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy; Department of Anesthesia, Critical Care and Emergency, ASST Spedali Civili of Brescia, Italy.

Silvia Barbieri (S)

Department of Anesthesia, Critical Care and Emergency, ASST Spedali Civili of Brescia, Italy.

Frank Rasulo (F)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy; Department of Anesthesia, Critical Care and Emergency, ASST Spedali Civili of Brescia, Italy.

Nicola Latronico (N)

Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Italy; Department of Anesthesia, Critical Care and Emergency, ASST Spedali Civili of Brescia, Italy.

Massimiliano Gobbo (M)

Laboratory of Integrative and Clinical Physiology (FCI lab), University of Brescia, Italy; Department of Clinical and Experimental Sciences, University of Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH